Adjusting weight to reflect group differences in Model [General Sta­tis­tics]

posted by dshah  – India, 2022-03-29 20:40 (1543 d 14:09 ago) – Posting: # 22884
Views: 5,249

Dear Balakotu!
As per EMA- In parallel design studies, the treatment groups should be comparable in all known variables that may affect the pharmacokinetics of the active substance (e.g. age, body weight, sex, ethnic origin, smoking status, extensive/poor metabolic status). This is an essential pre-requisite to give validity to the results from such studies.
In general, it is recommended to have balanced between treatment arms.
Regards,
Divyen

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
140 visitors (0 registered, 140 guests [including 14 identified bots]).
Forum time: 10:50 CEST (Europe/Vienna)

I have finally come to the konklusion
that a good reliable set ov bowels
iz worth more to a man
than enny quantity of brains.    Josh Billings

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5